Low dose, oral epsilon aminocaproic acid for renal papillary necrosis and massive hemorrhage in hemoglobin SC disease

Renal papillary necrosis in sickling hemoglobinopathies can lead to significant complications, including hemorrhage, obstruction, and infection. Despite its frequency, there are limited therapies for protracted hemorrhage. In the past, massive hemorrhage was managed with nephrectomy. Here, we report a patient with hemoglobin SC disease and prolonged, life‐threatening hemorrhage from papillary necrosis successfully treated with oral, low‐dose epsilon aminocaproic acid (EACA). Although further study is warranted, this case illustrates the need to consider EACA in the conservative management of renal papillary necrosis and significant hemorrhage in sickle cell hemoglobinopathies. Pediatr Blood Cancer 2010; 54:148–150. © 2009 Wiley‐Liss, Inc.

[1]  K. Ataga,et al.  Hypercoagulability in sickle cell disease and beta-thalassemia. , 2008, Current molecular medicine.

[2]  K. Kiryluk,et al.  Sickle cell trait and gross hematuria. , 2007, Kidney international.

[3]  W. Abdullah.  Pediatr Blood Cancer , 2004 .

[4]  S. Vijayaraghavan,et al.  Sonographic Features of Necrosed Renal Papillae Causing Hydronephrosis , 2003, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[5]  M. Sarnak,et al.  Epsilon-aminocaproic acid and renal complications: case report and review of the literature. , 2002, Clinical Nephrology.

[6]  L. Chan,et al.  Outcome in hemoglobin SC disease: A four‐decade observational study of clinical, hematologic, and genetic factors , 2002, American journal of hematology.

[7]  B. Brandt,et al.  Massive Gross Hematuria in a Sickle Cell Trait Patient with Renal Papillary Necrosis , 1998, European Urology.

[8]  J. Lohr,et al.  Renal papillary necrosis in a patient with sickle cell trait. , 1997, Journal of the American Society of Nephrology : JASN.

[9]  R. Emery,et al.  Decreased postoperative drainage with addition of ϵ-aminocaproic acid before cardiopulmonary bypass , 1994 .

[10]  H. T. Milhorn,et al.  Gross hematuria in a patient with sickle cell trait. , 1985, Postgraduate medicine.

[11]  G. Eknoyan,et al.  Renal Papillary Necrosis: An Update , 1982, Medicine.

[12]  S. Acchiardo,et al.  Aminocaproic acid in prolonged hematuria of patients with sicklemia. , 1976, Archives of internal medicine.

[13]  M. Koshy,et al.  Renal papillary necrosis in sickle cell hemoglobinopathies. , 1976, The Journal of urology.

[14]  D. Eckert,et al.  The incidence and manifestations of urographic papillary abnormalities in patients with S hemoglobinopathies. , 1974, Radiology.

[15]  T. Allen,et al.  Insoluble fibrin clots within the urinary tract as a consequence of epsilon aminocaprioic acid therapy. , 1972, The Journal of urology.

[16]  V. Buckalew.  Sickle-cell nephropathy. , 1970, Annals of internal medicine.

[17]  L. W. Statius van Eps,et al.  Nature of concentrating defect in sickle-cell nephropathy. Microradioangiographic studies. , 1970, Lancet.

[18]  D. Purtilo,et al.  Glomerular capillary thrombosis and acute renal failure after epsilon-amino caproic acid therapy. , 1969, The New England journal of medicine.

[19]  J. Bergin.  The complications of therapy with epsilon-aminocaproic acid. , 1966, The Medical clinics of North America.

[20]  F. Mostofi,et al.  Lesions in kidneys removed for unilateral hematuria in sickle-cell disease. , 1957, A.M.A. archives of pathology.

[21]  Jackson Mh.  Tubal patency tests. , 1947 .

[22]  R. Emery,et al.  Decreased postoperative drainage with addition of epsilon-aminocaproic acid before cardiopulmonary bypass. , 1994, The Annals of thoracic surgery.

[23]  S. Laskownicki.  [Treatment of so-called essential hematuria]. , 1959, Urologia internationalis.